Article
mTOR inhibition reverses Akt-dependent prostate intraepithelial neoplasia through regulation of apoptotic and HIF-1-dependent pathways.
Nature medicine - 1 Jun 2004
Majumder Pradip K, Febbo Phillip G, Bikoff Rachel, Berger Raanan, Xue Qi, McMahon Louis M, Manola Judith, Brugarolas James, McDonnell Timothy J, Golub Todd R, Loda Massimo, Lane Heidi A, Sellers William R
Abstract excerpt
Loss of PTEN function leads to activation of phosphoinositide 3-kinase (PI3K) signaling and Akt. Clinical trials are now testing whether mammalian target of rapamycin (mTOR) inhibition is useful in treating PTEN-null cancers. Here, we report that mTOR inhibition induced apoptosis of epithelial cells and the complete reversal of a neoplastic phenotype in the prostate of mice expressing human AKT1 in the ventral...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
